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WELCOME TO DEAN WARWICK 
It is with great pride that the J ournal staff announces that Dr. 0 . H . Warwick has 
consented to be the Honorary Staff Advisor to the J ournal. 
As you wi ll read in the informative, yet humorous biog raphy by Dr. Manning, Dean 
Warwick has been associated with the Chemotherapy of Cancer as a N uffield Fellow in 
England, as the first Med ical D irector of the N ational Cancer Institute, and as Senior 
Physician at the Ontario Cancer Institute, and the adjoining Princess Ma.rgaret Hospital 
in Toronto. 
It is with great pleasure that the Journal dedicates th is issue to ou.r newly appointed 
Dean, Dr. 0 . H . W arwick . 
DR. 0. H. WARWICK 
MESSAGE FROM THE DEAN 
To my predecessor in office, Dr. Collip, I express my t hanks, and those of my 
colleagues, for the very active and progressive school which he has left to our care. 
Medical education, research and practice are finely inter-woven in a pattern 
which we know to be constantly changing. My function as Dean wi ll be primarily 
to coordinate within the un iversity fami ly the efforts of our teachers and research 
workers. The ultimate purpose of the efforts of all of us is to produce good doctors 
and to advance medical knowledge. 
I w.:>uld like the undergraduates to real ize that the Dean took a medical course 
similar to yours twenty-five years ago and that he is willing at all times to share 
the intervening years of experience with any student who finds himself in difficulty 
or trouble. You will find him an easy-going fellow with a sense of humor which 
will cease to exist only when the conduct and behavior of students fall below 
standards which befit doctors and the profession of medicine. 
He is contrary enough also to believe that being the 13th Dean of this Fa.culty 
of Medicine is a good omen, not a bad one. He looks forward to his years with you 
and with those who follow you. 
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Dr. 0. H. Warwick 
Dean of Medicine 
For the past fourteen years, Western has 
had the privilege of having as Dean of 
Medicine one of Canada's outstanding 
scientists. Dr. Collip has brought recogni-
tion to <this school far beyond that which 
most of us realize. We are now entering a 
new era which in the years .to come will 
see an even greater medical centre here at 
our University of Western Ontario. Those 
responsible for the long term planning of 
our University and Medical School have 
been successful in obtaining a successor for 
Dr. Collip, who, from his repuation as a 
scientist, clinician and administrator, will 
certainly continue the tradition of this 
school and its aims, to provide an even 
greater educational and research centre for 
Canada. 
Dr. Warwick was born in 1915 at St. 
John, N .B. Following graduation from St. 
John High School, he proceeded to Mount 
Allison University, N .S., completing his 
B.A. degree in 1935. He then attended 
McGill, where in 1936, as an undergrad-
uate medical student in his first year, he 
was awarded the Rhodes scholarship. The 
Rhodes, as we are well aware, is given not 
only for outstanding scholastic achieve-
ment, but also for general proficiency, in-
clud!ng sports which in his case included 
basketball and hockey (both of which re-
quire a good deal of active mobility which 
he continues to demonstrate to a consider-
able degree). 
During the next two years, he completed· 
hi$ B.A. and M.A. degrees in physiQlogy . 
in the Honors School at Oxford. Across 
the · tabie in ·the physiology iaboratory at 
Oxford, he met and became closely associ-
DR. GEORGE W. MANNING, 
M.A., M.D., PhD., F.R.C.P.(C). 
ated with another Rhodes scholar from 
Australia, our Professor of Biochemistry, 
Dr. Roger Rossiter. Those were the days 
before the War and I am sure that many 
of them were spent both at study and 
indulging in a good old "spot-of-tea" in 
their "digs" or the local Oxonian "tea 
houses" following their day of exposure to 
the lectures and laboratory sessions provid-
ed by the Dons of Oxford. Dr. Warwick 
returned to McGill followi ng the comple-
tion of his work at Oxford and continued 
a brilliant academic career, graduating in 
1940 with the M.D .C.M. as the Wood 
Gold Medalist. Immediately after gradua-
tion, he became a junior intern at the 
Royal Victoria Hospital in Montreal, 
where his first patient was the late Maude 
Abbot. Perhaps many of you do not re-
member Dr. Maude Abbot. This little old 
lady of moderate proportions was, how-
ever, the founder of Pediatric Cardiology 
as we know it to-day. Her study and classi-
fication of congenital heart disease in 1,000 
cases was without doubt the stimulus that 
led to the further work of Taussig and 
Blalock and the great host of research and 
investigation that has led to our present 
day approach to the diagnosis and treat-
ment of congenital heart disease. She was 
truly a forerunner of Pediatric Cardiology 
not only in Canada but in the entire world 
.-a "St. John crying in the wilderness" as 
McMurrich so aptly applied to Leonardo 
da Vinci. This was our Dean's first patient 
whom he had the privilege of treating in 
her last illness, an.d. I may venture to say 
_h_e has had no_· more·. p~~ant, app~eciati~e 
·and, perhaps, "important patient, · ·pa-rticu-
larly to cardiology; to serve'since that time. 
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Following this brief internship at the 
Royal Victoria Hospital in Montreal, Dr, 
Warwick, along with practically all the 
other young physicians of those rather 
gloomy years, whose services to the armed 
forces were urgently required, enlisted in 
the R.C.A.F. 
My first contact with him was in 1941 
when he was posted to No. 2 R.C.A.F. 
clinical investigation unit at Regina. First 
impressions are interesting to reflect upon. 
Here was an active, "continually moving" 
young man, with a sense of humor, ability 
of expression, wit, knowledge and keen 
observation. "Hal" as we came to know 
him, never could or did keep still and cer-
tainly the saying that no one ever stands 
still, he either moves backward or forward , 
applied here. It was obvious from the be-
ginning that the direction was forward . 
Following a short tour of duty at Regina 
Dr. Warwick proceeded to the "Y" depot 
at Halifax where he was responsible, with 
Dr. C. B. Stewart, now Dean of Medicine 
at Halifax, for the high altitude selections 
program. In 1943, he proceeded over-
seas where he served the Canadian Bomber 
Group. At the end of hostilities, he return-
ed to McGill where the late Professor J. C. 
Meakins offered him the post of Resident 
in Medicine at the Royal Victoria Hospital, 
for which the competition at the time, with 
so many return ing for training, was most 
acute. This year was a most successful and 
satisfactory year both for Hal and the 
Royal Victoria Hospital, following which 
he was selected as McGill's choice for one 
of the first four Nuffield Fellowships of-
fered to Canada. During the year 1946-47, 
he obtained the M.R.C.P. degree (on the 
first attempt) and worked at both the 
Royal Cancer Hospital and Brompton 
Chest Hospital, where he was one of the 
first to investigate the value of nitrogen-
mustard in the treatment of bronchogenic 
carcinoma. During this year, he assisted in 
the investigation of and application of 
other forms of chemotherapy in the cancer 
field, which of course provided an excel-
lent background for the specialty with 
which he later associated himself. 
This was a year of austerity in England 
with food and fuel rationing so severe that 
the Warwicks used to bed down at night 
in "ski suits" . Their third child, Peter, was 
born in Old London at "Withering 
Heights", during that fueless and foodless 
year. An egg was indeed a rarity, milk 
rationed so severely that one was forced 
to drink beer (unpasteurized). The weekly 
"joint" was obtained by using all the 
points one could muster and was sort of a 
newspaper wrapped surprise package 
which had to be obtained from the one 
butcher on your list. In spite of the dif-
ficulties he managed to enjoy what I am 
sure was a most valuable year; for the 
Nuffield Foundation had been most co-
operative (except for the stipend) in ob-
taining the various posts, courses, etc. in 
which he was interested. Since it was 
obvious that the amount of the Fellowship 
would fall considerably short of support-
ing him and his family for the year, it was 
necessary to either borrow or by some 
devious manner acquire additional funds. 
H al hit upon an ingenious scheme. It start-
ed with a desire of a wealthy Scottish 
friend for an American Buick car (at any 
cost). Hal bought the Buick, delivered in 
packing case at the port of London, at a 
cost of approximately 2,000.00. (He, of 
course, had to learn to drive in the mean-
time!) Having possessed the car for a very 
short period, he was then free to sell it 
and this was done to the Scot for approx-
imately $4,000.00, leaving a good profit 
and a good deal of lumber from the pack-
ing case, which also proved most useful for 
sundry purposes. "Project Buick" had been 
a most satisfactory venture not only for 
"car Salesman for a day" Warwick, but 
also for me, for I was able to borrow a 
large number of five pound notes (at no 
interest) allowing me also to get back to 
Canada. (This, by the way, was a legiti-
mate way to get money out of England, 
difficult at that time!) 
f2~ 
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Returning to Canada after a most suc-
cessful year in London, and one of which, 
I am sure, he will have many fond mem-
ories, Hal entered private practice in 
Montreal as an internist attached to the 
teaching staff of the Royal Victoria Hos-
pital. After one year, he was invited to 
become the first Medical Director of the 
National Cancer Institute. He ·then moved 
to Toronto to take up this position, and, 
as well, a staff appointment at the Toronto 
General Hospital. In 1955, with t he crea-
tion of the Ontario Cancer Institute and 
Princess Margaret Hospital in Toronto, he 
left the National Cancer Institute to be-
come senior physician at this institution, 
and Assistant Professor of Medicine at the 
University of Toronto, which positions he 
occupied until coming •to Western in July 
1961. His particular research interests have 
been in the fields of chemotherapy of ma-
lignant disease and in .the various metabo-
lic disorders associated with this group of 
diseases, and he has to his credit a large 
number of research publications in this 
field. For three years, he represented the 
British Commonwealth in the International 
Union against cancer. 
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Dr. Warwick's esteem of the University 
of Western Ontario is apparent from the 
fact that his oldest daughter, Wendy, had 
registered at U.W .O. sometime before he 
was invited to accept the position of Dean 
of Medicine at Western. 
Our new Dean has many accomplish-
ments, one of the most important being 
the acqu isition, a "few" years ago, of a 
most charming wife. Their four children-
Wendy, Glynn, Peter and Vicky, being the 
offspring of remarkable parents will, I am 
sure, continue the Warwick traditions of 
active progress coupled with humility and 
the ability to make every situation pleas-
antly successful 
There is no doubt that we can look for-
ward to a most productive and pleasant 
administration of the medical faculty dur-
ing the coming years. As a personal friend 
of Dean Warwick, I am sure that he will 
excuse this rather informal introduction, 
and , knowing him as I do, I can assure 
you that there should be no hesitation 
whatsoever in seeking his advice whenever 
you have problems with which he may be 
able to help you. 
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Forward 
Recent Trends 
In Cancer Dlness 
With the conquest of infectious diseases, 
and the increasing age of our population, 
cancer has risen in importance as a cause of 
illness and death. Since 1937, it has been 
second only .to heart disease as the cause 
of death on this continent. In addition to 
this relative increase in cancer mortality, 
most observers feel that there is an abso-
lute increase in the cancer death rate. 
Many factors seem to be related to can-
cer illness. These include age, race, place 
of residence, stage of illness at time of 
diagnosis, and sex. In the last twenty years, 
the cancer mortality rate for men has risen 
significanly, while that for women has 
fallen . The maio site responsible for this 
incre:lSed mortality in the male population 
is the respiratory system and particularly 
the bronchi. There have been lesser but 
still significant increases in male mortality 
due to cancer of the urinary and genital 
organs, leukemias, and lymphatic and hem-
atopoietic system malignancies. The male 
mortality rate from cancer of the buccal 
cavity and stomach has decreased signifi-
cantly. No significant change has occurred 
in the male mortality rate from cancer of 
the intestines including the rectum. 
In females, the main cause for the de-
cline in the cancer mortality rate has been 
due .to the falling mortality from cancer 
of the body of the uterus. This is particu-
larly striking since the rate from carcinoma 
of cervix has risen while the overall rate 
for the uterus has fallen. In females, too, 
there has been an increased cancer mortal-
ity rate from leukemias, and lymphatic and 
hematopoietic system malignancies, but a 
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decrease in the rate from cancer of the 
stomach. No increase has occurred in the 
mortality rate from cancer of the rectum, 
but the rate from cancer of the intestines 
has fallen . T here has also been no signifi-
cant change in the female mortality rate 
from cancer of the buccal cavity, respira-
tory system, urinary organs and breast. 
In all of the sites mentioned, the mortal-
ity rates have been, and continue to be 
higher in males than females except in 
cancer of the intestines, not including the 
rectum. A further, interesting relationship 
between sex and cancer illness is seen when 
the cancer incidence rates are considered. 
Male cancer incidence rates for non-repro-
ductive organs are higher at all ages. 
However, the cancer incidence rates for 
reproductive organs, including breast, are 
greater for females until age 70. 
Besides its relative increase as a cause of 
morbidity and mortality, cancer has come 
to enjoy a far more important place in the 
medical and lay mind. It has become the 
subject of a major part of t oday's medical 
speculation and research in the search for 
its etiology and means of treatment. 
The term "cancer" comes from a Latin 
term for a crab. Paul of Aegina claims that 
it is so-called because " it adheres to any 
parts which it seizes upon in an obstinate 
manner like a crab" (Skinner). The auth-
ors of the various articles in this journal 
have attempted to show how modern med-
ical methods have succeeded in loosening 
the crab's feet. J,t remains for the doctors 
of the future to remove the menace of the 
crab's body . 
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Vincaleukoblastine: 
A New Chemotherapeutic 
Agent 
BARRY WRIGHT, '62 
INTRODUCilON 
The discovery and isolation of Vincaleukoblastine is an example of how a 
chance observation can lead to the development of a valuable clinical adjunct in 
the treament of disease. 
THE EARLY WORK 
In 1949, when the investigation that led 
to the isolation of Vincaleukoblastine 
(VLB, or Vinblastine Sulfate) was launch-
ed, Dr. R. L. Noble and his colleagues at 
the Collip Medical Research Laboratory 
were interested in the extracts of plants 
reputed by folklore and historical hearsay 
to have medicinal properties. The chemo-
therapy of cancer was not under consider-
ation when they heard of a tea made from 
the leaves of a West Indian shrub, the 
white-flowered periwinkle, or Vinca rosea 
Linn, which was said to be useful in <the 
treatment of diabetes mellitus. This plant 
had been used throughout the world for 
the treatment of a variety of conditions, 
and as early as 1910 had been described as 
having healing properties. In Europe, it 
was used for the suppression of lactation; 
in the British West Indies, for the treat-
ment of diabetic ulcers; and in the Phili-
pines, as an oral hypoglycemic agent_ It 
was therefore decided that an investigation 
of the effects of the extract on blood sugar 
should be undertaken, and a supply of the 
leaves was obtained from Black River, 
Jamaica. 
It was disappointing to find that an 
aqueous extract of the leaves, when admin-
istered orally, had no effect on the blood 
sugar of either normal or diabetic rats or 
rabbits. Doctors J. C. Rathbun and H. A. 
McAlpine of this University even visited 
Jamaica briefly to investigate the claims 
for the effectiveness of the plant in dia-
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betes mellitus. When the aqueous extract 
was injected intraperitoneally into rats, the 
effect soon became obvious. In most cases, 
death followed in 5-7 days, and autopsy 
showed multiple ascesses resulting from a 
septicemia. Dr. R. G. E. Murray of the 
Department of Bacteriology consistently 
reported the presence of Pseudomonas in 
the exudates. By coincidence, the same 
findings were obtained from other labora-
tory animals receiving large doses of cor-
tisone. It was concluded, then, that death 
in both experiments followed the suppres-
sion of some mechanism of defense against 
infection. Further studies showed that the 
periwinkle extraot caused a granulocyto-
penia and depression of the bone marrow. 
The investigation was continued rather 
sporadically, as time allowed, until 1955, 
when an intensive chemical study was 
organized. The first step was to compare 
the activity of various species of the shrub 
and the different parts of the individual 
plant. The active principle was located in 
the root, stem and leaves, the latter being 
most active, but the seeds were inactive. 
Cultivation of the plant as an annual was 
undertaken near London, Ontario, but the 
yield of the active substance was found to 
be only one-quarter of that of the peren-
nial which grew wild in the West Indies. 
Careful assessment of each step of the 
fractionation process, and bioassay of each 
fraction obtained, based on the peripheral 
leukopenia and marrow depression, show-
ed that a number of fractions with differ-
ent properties and degrees of activity 
could be isolated. 
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CHEMICAL AND BIOLOGICAL 
STANDARDIZATION 
Best results were obtained by extraction 
with an ethanol-acetic acid solvent. A num-
ber of fractions were then identified in the 
extract, the most potent being Fraction 9. 
The active substance in this fraction, which 
was then named Vincaleukoblastine, was 
found to be an alkaloid with the empirical 
formula, c .GH5 OuN •. It was purified and 
obtained as the crystalline sulfate for bio-
logical studies, but because this produced 
ariable results on intraperitoneal injection, 
the free base in propylene glycol became 
the standard preparation. Normal rats 
showed a severe granulocytopenia lasting 
3-5 days, followed by a rapid recovery. 
Weight loss was constant, but there was no 
effect on the gut, or on the regenerating 
liver in partially hepatectomized rats. The 
effect of stibestrol on the rat uterus was 
antagonized by VLB. It was found that an 
amount of the drug equal to 3-4 times a 
single lethal dose could be given over a 
ten day period. Mice bearing standard 
experimental tumors (leukemias, Ehrlich 
ascites tumor, mammary tumor) survived 
significa ntly longer when given VLB soon 
after the injection of the tumor cells. Sur-
vival was prolonged also by the pre-treat-
ment of the innoculurn, but not of the 
mice themselves. In fact, the pre-treated 
mammary tumor did not grow at all, but 
when the animals were given untreated 
tumor cells, later, they died after the 
average interval. VLB had a striking effect 
in clearing the peripheral blood of circu-
lating myeloid leukemic cells, although 
survival time was not increased. The most 
effective dose schedule was a 24-hour treat-
ment period, rather than a long series of 
daily injections. 
CLINICAL STUDIES 
Because in animal studies VLB showed 
some promise of effectiveness as an anti-
leukemic agent, a number of investigators 
undertook clinical studies on selected cases. 
NOVEMBER, 1961 
A wide variety of tumors were treated 
with VLB, but those responding best in-
cluded hemopoietic tumors (monocytic and 
myeloblastic leukemias, leuko-lymphosar-
coma, Hodgkin's Disease) and chorior-
carcinoma, of which two cases showed 
some regression of pulmonary metastases. 
One case of adenocarcinoma of the colon 
appeared to be improvedt but_ \~ors of 
nerve tissue, vascular tissue, smooth muscle 
and connective tissue were unresponsive. 
Although the most effective dose schedule 
has yet to be determined, the drug was 
usually given in a daily dose of 0.15 
mg./kg. into the tubing of an intravenous 
infusion of saline or glucose, for 3 or 4 
consecutive days, and repeated if necessary 
when the toxic effects subsided. In a recent 
study conducted by a group headed by Dr. 
0 . H . Warwick, ten doses of 0.02 mg./kg. 
were given at hourly or half-hourly inter-
vals, and repeated in one week if the leuk-
ocyte count exceeded 3,000 per cu. mm. 
Treatment was continued as long as 8 
months with relatively few side effects. 
There have been numerous manifesta-
tions of toxic side effects, but none was 
serious enough to warrant discontinuation 
of treatment. VLB is locally destructive, 
causing thrombophlebitis when injected 
directly into a vein. The systemic reactions 
recorded by various authors include: 
1. Anorexia, nausea, vomiting 
2. Weight loss 
3. Dizziness 
4. Depression and behavioral changes 
5. Some suppression of deep tendon re-
flexes 
6. Paresthesia of fingers and feet 
7. Bilateral pain and tenderness of the 
parotid glands with mouth dryness 
8. Constipation and urinary retention 
9. Decrease in hemoglobin 
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10. Inhibition of erythropoiesis 
11. Occasionally a slight depression of 
platelet count 
12. Stomatitis 
13. Partial to complete alopecia ( latter 
~as re1rersible) 
There ~ere no abnormalities of urinalysis, 
liver function tests, blood pressure, serum 
electrophoretic pattern, or fluid balance. 
SUMMARY 
VLB (Vinblastine), an alkaloid from the 
plant Vinca rosea, is a ne~ chemotherapeutic 
agent of limited usefulness in the treat-
ment of malignant and allied diseases. It 
has only a slight and temporary effect on a 
broad spectrum of solid tumors, but is of 
definite clinical value in the management 
of choriocarcinoma and Hodgkin's D isease. 
With regard to the latter ~o diseases, it 
has been pointed out that the use of VLB 
should be reserved until after conventional 
therapy has been given. 
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Perfusion for the Chemotherapy 
of Cancer 
R. SHEPHERD, '63 
INTRODUCilON 
The results of 'using chemicals for the treatment of cancer are generally dis-
appointing because drugs now available damage normal as well as malignant 
tissues. Recently, the tumor region has been isolated and perfused through an 
extra-corporeal circulation in an attempt to increase the dose of the drug to the 
tumor, and decrease its effect on the rest of the body. 
AGENTS 
Alkylating agents and antimetabolites 
are the commonest of many types of drugs 
used clinically. Alkylating agents produce 
a cytolgic effect similar to that of radio-
therapy, and are at times referred t o as 
" radiomimetic". Nitrogen mustard, the 
foremost of these is taken up by the tissues 
within minutes, whereas Thio-TEPA re-
mains acti e for several hours and is not so 
useful for perfusion. Antimetabolites such 
as the folic acid analogue, Methotrexate, 
and the purine analogue, mercaptopurine, 
are incorporated into tissues very slowly 
and are therefore not used in perfusion. 
TECHNIQUE 
Drugs have been injected locally into the 
artery supplying the tumor region to de-
liver a larger dose to the growth. A rapidly 
inactivated drug, and partial venous occlusion 
may be used to enhance the localization of 
activity of the compound. A larger dose 
has been obtained by isolating the blood 
supply of the tumor region by sphygmom-
anometer cuffs around limbs, or by clamps 
applied to the vessels. An artery and a vein 
in the isolated region are <then cannulated 
and connected to an extra-corporeal circula-
tion containing a pump and oxygenator. 
The fluid can then be recirculated through 
the tumor region and the amount which 
will leak into the general circulation will 
depend on the euent of the collateral ves-
sels which have not been occluded. The 
amount of leakage, which is further de-
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creased by maintaining the perfusion pres-
sure at a level lower than that of the 
general circulation, can be found by the 
inclusion of labelled red blood cells or 
RISA in the perfusate. The use of any 
long-acting compounds in perfusion re-
quires that they be re!Jloved from the 
circuit before normal circulation in the 
region is re-established. The procedure can 
then be used for the treatment of locally 
advanced lesions, or as an adjunct to sur-
gery or radiotherapy in an attempt to de-
crease the incidence of cancer recurrences. 
EXPERIMENTAL WORK 
Animal experiments were required to 
deter:mine ·the most suitable time period 
and pressure for perfusion, and the maxi-
mum tolerable dose. Duration of activity 
of the chemotherapeutic agent was deter-
mined by bioassay studies. Working with 
the hind limb Qf the dog, and using the 
femoral vessels to perfuse, Creech found 
that a dose of 2 mgm./kg.of PAM(phenyl-
alanine mustard) produced no ill effects. 
This is equivalent to the safe oral dose, or 
twice the systemic dose. Since the hind 
limb of .the dog represents only 1/20 the 
total body weight, the concentration ach-
ieved by this method far exceeds that made 
possible by earlier techniqu~. Attempts to 
further increase the effect on the rumor 
have involved the use of a perfusate 
having a very high 0 2 tension, perfusion 
with drug combinations, and the use of 
radiotherapy along with perfusion. 
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CLINICAL APPLICATION 
This procedure has been used in patients 
with malignant disease judged refractory 
to conservative treatment such as radio-
therapy. The method of isolating the 
region varies from site to site. In the limbs, 
a tourniquet can be applied and the femoral 
vessels cannulated in the leg, while in the 
arm and forearm the axillary artery and vein 
may be used. Cannulation of the third part 
of the subclavian artery will permit per-
fusion of the axillary lymph nodes, which 
is important if these nodes are involved. 
Perfusion of the pelvic region requires 
occlusion of the aorta and inferior vena 
cava below their renal branches, and can-
nulation of these vessels above their bifuca-
tion. Tourniquets applied to the lower 
extremities then complete isolation of the 
extra-corporeal circuit. Perfusion of the 
lung is a major procedure and requires two 
extra-corporeal circuits. The first cicuit is 
used to perfuse the lung by a left atrium 
to pump-oxygenator to pulmonary artery 
circuit, while the second circuit maintains 
the systemic circulation by a venae cavae to 
pump to oxygenator to femoral artery cir-
cuit. Mixing of the systemic and perfusing 
circuits is prevented in this case by caval 
occlusion and the isolation is very efficient. 
In the extremities, mixing is slight, and 
dosage is limited by the reaction of local 
tissues to the agent. In most other sites 
where tourniquets are ineffective and leak-
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age is high, dosage is limited by the danger 
of systemic effects. 
Perfusion has been carried out on locally 
advanced lesions involving the limbs, 
pelvis, lungs, breast, brain, transverse 
colon, and scapula, with improvement in 
about 1/ 3 of cases. Complete regression of 
a tumor has never occurred. The results of 
perfusion to prevent recu rrence after surg-
ical excision of the primary tumor are not 
available. 
SUMMARY 
A tumor may now be treated with a 
large dose of a drug, using an extra-cor-
poreal circulation. The commonly used drugs 
are nitrogen mustard, Thio-TEPA and 
PAM. Best results are obtained when the 
lesions in limbs are perfused because a 
much larger dose can be delivered. One 
third of cases selected for this form of 
therapy show improvement. 
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Supervoltage Therapy 
TERRY CULLEN, '63 
INfRODUCfiON 
In the past decade, cobalt-60 beam therapy and supervoltage x-ray therapy have 
been made available for the treatment of cancer. Both of these offer ma.rked 
improvement over conventional ray therapy and both can be included under the 
title of upervoltage Therapy. 
DEFINITION 
Supervoltage Therapy is the term used 
in therapeutic radiology when referring to 
treatment using very high energy, short 
wavelength radiations. The energy of the 
radiations ranges from one million to one 
hundred million electron volts, (1-100 
MeV) , but only between one to thirty MeV 
is commonly used today. The two types of 
energy beams by far t he most commonly 
employed are gamma-rays and supervoltage 
x-rays . At the present time, the term Super-
voltage Therapy applies most properly in the 
clinical , but not experimental sense, to high 
energy gamma and x-ray therapy. 
PARTICLES AND RAYS USED 
IN THERAPY 
There are many different particles and 
rays which are used in varying amounts 
for therapy, and, for the sake of complete-
ness, these are listed below. They include 
the two this paper shall discuss, namely, 
x-rays and gamma-rays. 
Charged particles 
electrons or beta particles 
protons 
alpha particles 
Uncharged particles 
neutrons 
Electromagnetic rays 
x-rays 
gamma-rays 
X-RAYS AND GAMMA-RAYS 
In order to appreciate the term Super-
voltage therapy, an understanding of rays 
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in general is necessary, as well as some 
knowledge of both radiosensitivity and 
radiocurability. Below is an outline of 
these. 
Gamma-ray Production 
Gamma rays are spontaneously emitted 
from the nuclei of disintegrating radio-
active isotopes, usually along with alpha 
or beta particles or both. Alpha particles 
(posi ti ve helium nuclei ), and beta particles 
(negative electrons) , are both charged and 
have mass, but neither is used to any great 
degree in medicine at present. From radio-
active isotopes, usually only gamma-rays 
are allowed ,to reach living tissue. 
Examples of radioactive isotopes are 
Radium (Ra226 ) and Cobalt (Co60), where 
the number indicates isotopic weight. 
RAdium 
Radium is a naturally occurring element 
which has a half-life of 1,620 years and 
which produces a whole series of disinte-
gration products, finally becoming lead. 
Alpha and beta particles and gamma-rays 
are emitted during the disintegration pro-
cess. Radium has been replaced in the last 
decade by Cobalt-60 which has many 
advantages over Radium. 
Disadvantage of RAdium as a beam source 
1. I·t is hard to prepare and difficult to 
handle. 
2. There is a possibility of leakage, causing 
contamination. 
3. It is expensive. 
4. It is not available in great quantity. 
Advantage of Radium 
It has a long half-life and hence is useful 
for a long period of time. 
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Cobalt 
Cobalt-60 is an artificially made isotope 
which emits primarily very high energy 
gamma rays and which has a half-life of 
5.3 years. The two gamma-rays emitted 
have energies in the supervoltage range, 
these being 1.17 and 1.33 MeV. Cobalt-60 
rays are an excellent alternative to high 
energy x-rays produced by supervoltage 
x-ray machines. 
X-Ray Production 
X-rays a e produced by x-ray tubes only. 
Such a tube is an evacuated device contain-
ing an anode and filamentous cathode, 
and arranged such that when voltage is 
applied, a stream of electrons is accelerated 
from the cathode •to the target anode where 
the kinetic energy of the electrons is trans-
formed into heat and x-rays. Actually, a 
whole spectrum of x-rays is emitted, all the 
wavelengths of which are small as compared 
with light or radio waves. 
Quality of X-rays 
It is possible, by using a filter, to absorb 
the longer wavelengths and allow only the 
shorter ones through. Further, by increas-
ing the voltage, more short waves will be 
produced. Thus, voltage and filtrati on .de-
termine the quality of the x-ray beam. 
Short waves have greater energy than long-
er waves and hence penetrate more deeply 
into matter. It shouJ,d be pointed out that 
x-ray machine input voltage, in the conven-
tional low range, is expressed in kilovolts 
(kV) where a kilovolt equals one thousand 
volts, and in tbe supervoltage range, in 
megavolts (MV) where a megavolt equals 
one million volts. 
Output energy from both x-ray and 
gamma-ray sources is expressed in MeV. 
The average quality of x-rays generated at 
one MV will be less than one MeV. Thus 
cobalt-60, at an average output energy of 
1.25 MeV equals the output of a 3 million 
volt (3MV) x-ray tube. 
i38 
Specific Methods of X-ray Production 
for Therapeutic Purposes 
1. Tramformer Rectifier 
This is useful for voltages up to one 
million but is used mostly in the region of 
250kV. 
2. Electrostatic systems 
The Van de Graaf type of generator 
exemplifies this and can excite x-ray tubes 
up to two million volts. 
3. A ccelerators 
For energies in the supervoltage range 
above two million volts, the direct use of 
high voltage is not practical and therefore 
device have been developed to utilize the 
same voltage repeatedly to build up the 
energy of the electrons. The two main types 
of accelerators are: 
1. Linear 
2. Cyclic; Betatron, Synchrotron. 
In .these, the particles are accelerated along 
a straight line or cyclic path. The linear 
accelerator has an energy range up to 5 
MeV, while the cyclic accelerator can de-
liver up to 50 MeV. 
Summary 
Originally, voltages used in x-ray ·ther-
apy were in the 100-400kV range. In 1936, 
a large one million volt unit was estab-
lished in London, England, and in the past 
decade or so, high speed accelerators have 
pushed output energy well over 1 MeV 
and truly into the supervoltage field . 
Nature of X-Rays and Gamma-Rays 
Both x-rays and gamma-rays are pa~t of 
the electromagnetic spectrum of wave-
lengths, and both are found at the extreme 
short wave part of the spectrum. X-ray 
and gamma-ray beams are streams of 
energy packets or quanta of energy which are 
called photons. Photons are weightless and 
chargeless energy packets: the energy they 
carry is measured in electron volts. 
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The Interaction of Rays With Tissue 
When ionizing radiation impinges upon 
tissue, energy is extracted by the tissue for 
certain interaction processes between it and 
the radiation beam. The amount of energy 
per gram of tissue can be measured or cal-
culated, and is expressed in rads. The rad 
is the unit of x- or gamma-ray dosage that 
is used in rad iotherapy. The relationship 
between energy abs.orbed and tissue re-
sponse is not completely understood at pres-
ent due to a lack of knowledge about living 
protoplasm itself. 
It is known that cells in mitosis and 
immature cells are quite sensitive to ir-
radiation, more so than other cells. The 
effects of irradiation may be outlined : 
Temporary effect 
The major effect is suppression of mito-
sis. This causes cessation of growth, and , 
with increasing ly greater doses, the dura-
tion of the mitosis-free period and hence 
growth-free period increases. 
Permanent effect 
The major effect is to damage the mitot-
ic mechanism. The amount of injury to the 
sensitive chromosomes depends on the 
dose; when high enough, the nuclei become 
large and hyperchromatic, chromatin tends 
to be dumped and nucleoli become promi-
nent. Bizarre and giant nuclei may appear 
in considerable numbers. 
It has been argued in the past that be-
cause of the similarity of these cells to the 
anaplastic cells of neoplasms, malignancy 
was increased after irradiation and that 
radiation was therefore stimulating. It is 
firmly established, however, that radiation 
produces ·~ellular injury, and, that while 
phenomena may take place that have the 
appearanc•: of proliferation or stimulation, 
the 'cell itself is always deleteriously 
affected . 
RADIOSENSITIVI1Y 
AND RADIOCURABILITY 
Radiosensitivity 
Any tissue or tumor can be destroyed if 
enough radiation is applied to it. In the 
NOVEMBER, 1961 
body, however, the magnitude of dose is 
limited by the tolerance of the normal 
tissue included in the irradiated volume. 
So we might say that tumors which are 
eradicated with the maximal or less than 
maximal permissible dose are radiosensi-
tive, while those not eradicated with the 
maximal permissible dose are radioresist-
ant, where the maximal permissible dose 
is determined by normal tissue tolerance to 
irradiation. 
In the body, the various normal tissues 
te~d to differ in their relative sensitivity 
to irradiation. For example, lymphoid tis-
sue is the most sensitive and nervous tis-
sue the most resistant. In general, the 
radiosensitivity of neoplasms tends to fol-
low that of the tissue from which the 
tumor is derived. Hence, lymphosarcoma 
and lymphatic leukemia are very sensitive 
to irradiation , while gliomas are relatively 
resistant. 
Many factors affect sensitivity. Two 
notable ones are: 
1. Cell of origin 
As stated above, when a normal cell be-
comes malignant, its radiosensitivity will 
be in the same order as that of its normal 
parent. 
2. State of cell 
Cells in mitosis are more sensitive than 
resting cells. 
Obviously, in cancer therapy, one must 
find that dosage which will give the opti-
mum result. How much radiation can or 
should be given to eradicate the tumor at 
the risk of destroying some normal tissue? 
With low doses, the risk of recurrence is 
g reat and the danger of injuring the tumor 
bed small, while with bigger doses, the 
danger of injury is great and the risk of 
recurrence small. 
Radiocurability 
This term is not synonymous with radio-
sensitivity but is affected by radiosensitiv-
ity as well as by tumor type, infiltrative 
and metastatic extent of the tumor, site of 
the tumor, character of the tumor bed and 
time-dose-volume relationships. 
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For example, with Hodgkin's lympho-
sarcoma, radiosensitivity is high, but radio-
curability is low due to the metastatic 
capabilities of the tumor. On the other 
hand, carcinoma of the oral part of the 
tongue, if it has not metastasized or infil-
trated, is radiocurable because the tongue 
has a good vascular bed and is quite 
accessible, but the tumor itself is relatively 
radioresistant and requires high doses. 
SUPERVOLTAGE THERAPY 
Sires where applicable 
It is not wise to attempt a statistical 
evaluation of supervoltage therapy at the 
present time due to the variance of opinion 
from various centers. However, certain 
organs and reg ions have been found to 
respond much better with Supervoltage 
Therapy than with conventional, low volt-
age therapy. Below is a partial list of 
certain organs and regions in which super-
voltage therapy has been tried and in 
which a measure of success has been 
attained. 
Bladder 
Cervix 
Esophagus 
Lung 
Rectum 
Thyroid 
Middle ear 
Orbit 
Oral cavity 
Advantages of Supervoltage Therapy 
There are four main advantages of su-
pervoltage therapy over conventional low 
voltage therapy: 
1. Skin Sparing Effect 
With a 250kV machine, maximum ion-
ization occurs within the skin and produces 
severe skin reactions. With supervoltage 
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radiations, maximum ionization occurs be-
neath the skin and the patient experiences 
much milder superficial reactions. Helping 
to produce this effect is the fact that there 
is much less back scatter with high than 
with low energy radiations. 
Because of the decrease in severity of 
reactions, more patients are able to finish 
their therapy, and, since the last few 
hundred rads may determine the result of 
therapy, it can be appreciated why lessen-
ing skin reactions is so important. 
2. Greater penetration 
As wavelengths become shorter with in-
creasing voltage, the depth dose increases 
and so deep tumors anywhere in the body 
can be given a rational dose. 
3. Bo11e Sparing Effect 
With low energy rays, about ten times 
as much radiation is absorbed by bone as 
by soft tissue. With high energy rays, bone 
absorption is markedly decreased. There-
fore there is less chance of precipitating a 
pathological fracture after prolonged treat-
ment. Further, tumors on the far side of a 
bone will receive adequate treatment with 
high energy rays which will penetrate the 
bone without being markedly absorbed. 
4. Smaller dose to normal tiss11es 
Due to greater penetration of the high 
energy beams, fewer fields need be used 
in therapy with a resultant drop in dosage 
received by normal tissue. Further, less 
scatter in both lateral and backward direc-
tions results in confinement of the beam 
to a smaller field , and this too decreases 
normal tissue irradiation. 
Disadvantages of Supervoltage Therapy 
These have been overcome, for the most 
part, by modern techniques. 
1. Supervoltage equipment is initially 
quite expensive. 
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2. With supervoltage, devices are need-
ed to hold thick lead shielding. With low 
voltage, lead sheets can be placed on the 
patient. 
3. With 200kV, the exit dose is low and 
need not be g iven the attention of a super-
voltage beam exit dose. 
4. Above 5MeV, bone absorption again 
becomes greater than that of soft tissue. 
Cobalt-60 vs. Supervoltage X-ray 
Differences between cobalt-60 beam 
therapy and supervoltage x-ray are quite 
minor and not important clinically. Both 
do the same job. 
CONCLUSION 
Every volume, except superficial lesions, 
can be irradiated more easily with super-
voltage therapy than with conventional 
low beam therapy. Further, cure rates in-
crease in those patients whose only pre-
vious therapy was conventional low beam 
therapy. 
Supervoltage therapy, therefore, takes its 
place alongside other modes of treatment, 
THROMBOPHLEBITIS AND CANCER 
Lieberman, J.S., Borrero, J., Urdoneta, E., 
and Wright, I. S., JAMA, 177: 542-545, 
1961. 
Modern interest in the association of 
thrombophlebitis and cancer was revived 
by Sproul in 1938. This study demonstra-
ted multiple venous thromboses in 31 % of 
cases of carcinoma of the body and tail of 
pancreas. 
The present authors reviewed 1400 cases 
with diagnosis of thrombophlebitis or ven-
ous thrombosis, and found 81 to have 
associated cancer. In these cases of neo-
plasm, the thrombophlebitis tended to be 
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all of which are dedicated to the eradi-
cation of that terrible phenomenon known 
as cancer. 
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recurrent or migratory, and to appear in 
multiple extremities. One should probably 
note that widespread metastases were 
frequent. 
In this study, the lungs, female repro-
ductive tract, and the pancreas, in this 
order were the most frequent original sites. 
However, many other sites were also noted. 
In several cases, it took some time before 
the malignancy was discovered. Many of 
the cases were resistant to anticoagulation. 
Why such an association? The authors 
offered only comments on the elucidation 
of such a mechanism. 
Robert Moffat, '62 
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Preoperative Radiation 
M. D. MAYNARD, '62 
INTRODUCI'ION 
This particular topic is presently the subject of much controversy among surgeons 
and therapeutic radiologists . Therefore this paper will present only a few of the 
concepts in this controversial field . 
ADVANI'AGES AND AIMS OF 
PREOPERATIVE RADIATION 
1. To reduce the local vitality of the ma-
lignancy by marked reduction of its size or 
its rate of growth, so that operation can be 
carried out with a greater chance of eradi-
cation of the disease. 
2. To reduce the size of tumors where re-
section might otherwise be more difficult. 
3. If one agrees that there is a possibiiity 
of surgical manipulation disseminating 
malignant cells via vascular or lymphatic 
cba,nnels, and if one further agrees that 
radiation prior to surgerr. may devitalize 
these cells so that a chance of "take" at 
some distant lodgement is decreased , then 
preoperative therapy is a valid procedure 
(]. W. J. CARPENDER). Kaee backs up 
this assumption with figures on Grade 3 
Carcinoma of Breast. 
4. There is an intact blood supply in most 
cases which allows higher doses of irradia-
tion which may be more effec.tive than 
postoperative radiation. 
OBJECfiONS TO COMBINED 
PREOPERATIVE RADIATION 
THERAPY AND SURGERY 
1. The possibility that metastases will 
develop• while therapy is under way dur-
ing the waiting period. 
2. Irradiation effect is not maximal until 
two months after treatment. 
3. Possible increase in operative and post-
operative morbidity due to radiotherapy. 
There is a resultant increased vascularity 
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·and bleeding at surgery with the acute 
radiation reaction, and post-irradiation fi-
brosis may make operation and wound 
healing more difficult in the .later stages 
of treatment. 
4. Length and expense ~f treatment to the 
individual and the hospital. 
5. The psychological worry of delay 
through radiotherapy on the part of the 
patient. 
CONCLUSIONS 
Conclusions cannot be drawn from the 
above . lists of advantages and objections; 
they can only be made ov r a period of 
time as reports and comparisons of the 
various methods of treatment are made. 
Early results of the combined ::ttack with 
preoperative irradiation and appropriate 
surgery suggests that this combination of 
treatment is a real advancement in the 
<treatment of Bronchogenic Carcinoma. 
(Bloedorn and Cowley) 
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Mechanisms of Anemias 
ASSOCIATED WITH NEOPLASTIC DISEASE, 
With Special Reference To The Leukemias, 
I.ymphomas And Multiple Myeloma 
WILLIAM BROWN, '63 
INTRODUCI'ION 
Anemia is commonly associated with neoplastic disease and indeed, the first 
indication of an underlying neoplasm may be the signs and symptoms of an ~emi.a. 
Although variable in the picture presented, many of the mechanisms operattve m 
anemias of non-neoplastic origin may be operative also in anemias associated with 
neoplastic disease. 
Special reference will be made to anemias associated with neoplastic disease 
having origin in hemopoietic tissue because of the dose relationship, anatomically 
and physiolegically, which these neoplasms have to normal blood-forming tissues .. 
I propose to discuss the subject under the following headings, well recognizing 
the fact that a treatment of the subject in this way tends to separate the mechanisms, 
where in actual fact, in many patients, multiple mechanisms combine to cause the 
anemia. 
A. Hemorrhage 
B. Increased Hemolysis 
C. Relationship to Bone Marrow Metastases 
D . Effects of Therapy 
1. Ionizing Radiation 
2. Chemotherapy 
E. Nutritional Factors 
Special Reference to: 
1. Leukemia . 
2. Neoplastic Conditions chiefly involving the lymph nodes 
3. Multiple Myeloma 
HEMORRHAGE 
Chronic loss of blood as a cause of 
anemia in neoplastic disease is most fre-
quently the result of neoplasms involving 
the alimentary canal, the genital tract (par-
ticularly in females), and the urinary tract. 
A sustained loss of blood from an ulcer-
ated neoplasm leaes to a progressive fall 
in the hemoglobin level which, until it 
falls below 50%, may not be accompanied 
by the usual clinical signs of an anemia. 
The staining of feces, urine, discharges or 
vomitus is, however, often apparent to the 
patient. 
Such an anemia usually has the follow-
ing characteristic features: 
1. hypochromic and microcytic appear-
ing erythrocytes, 
2. a reticulocyte count rarely exceeding 
5%, 
3. a color index of around 0.6, 
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4. normoblastic appearing bone marrow. 
Hypochromic microcytic or iron defi-
ciency anemia are applicable terms. The 
sources of iron available for the erythro-
poietic system are dependent on first, a 
constant rate of absorption from the gas-
trointestinal tract, and second, iron storage 
in hemopoietic tissues. Here the constant 
loss of blood drains the available body re-
serves of iron, and although it is thought 
that in ,these anemias there is some increase 
in the absorption of iron from the gastro-
intestinal tract, this latter means of replen-
ishment is inadequate, resulting in the 
production : of erythrocytes deficient in 
hemoglobin (mean corpusQJlar volume 
<BO u.c. and mean corpuscular hemo-
globin concentration <30%) . An accom-
panying stimulation of erythropoiesis is 
similarly ineffectual in correcting the 
defect. 
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Although iron deficiency can result 
from continued bleeding from neoplasms 
involving the genito-urinary and respira-
tory tracts, bleeding from these sites of 
sufficient degree to cause anemia ts 
unusual. 
These anemias are amenable to t reat-
ment with iron but it should be pointed 
out that in some instances iron deficiency 
anemias may be complicated by other 
anemias not amenable .to iron treatment; 
for example those due to irradiation, 
chemotherapy, hemolysis and myelophthi-
sis . In these complicating anemias, the 
mechanisms are different and, therefore, 
the therapy of choice will be different. 
The hemorrhagic anemias so far d iscus-
sed are those due to hemorrhaging into a 
tube, but hemorrhage may also occur into 
the neoplasm itself. This type of blood loss 
is dinico-pathologically relatively insignifi-
cant in human neoplasms but not uncom-
mon in certain experimental tumors arising 
in and transplanted to rats. These tumors 
may be very large, to t he point of being 
heavier than the original weight of .the 
animaL Hemorrhage into these tumors can 
be quite severe and result in iron deficien-
cy anemia. 
INCREASED HEMOLYSIS 
Hemolytic anemia results whenever a 
decreased erythrocyte survival time ( nor-
mal 120 days) is not balanced by a suf-
ficient stimulation of erythropoiesis. A 
decrease in survival time of the erythro-
cytes to less than twenty days may be 
necessary to produce anemia if the bone 
marrow is functioning normaUy because 
the bone marrow has the capacity to in-
crease its erythrocyte production six fold . 
Thus, unless erythropoiesis is depressed for 
some reason, hemolysis and increased 
erythropoiesis characterize hemolytic an-
emia. The increased hemolysis is detectable 
by several techniques. Among them are 
tests which reveal: 
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1. increased excretion of fecal urobilin-
ogen, 
2. increased excretion of urinary urobil-
inogen, 
3. increase in the serum indirect acting 
bilirubin. 
The hemolytic anemia in patients with 
neoplastic disease is most likely due t o a 
changed environment in which these cells 
live. 
A possible clue to the mechanism in 
these hemolytic anemias is the detection of 
antibodies (agglutinating) in the serum of 
these patients. These antibodies have the 
ability to act on the host's own erythro-
cytes. In many instances these same anti-
bodies will react with a donor's red blood 
cells, suggesting that either the antigen or 
antibody concerned is not host-specific. 
There are two classes of hemolytic autoim-
mune anemias, the idiopathic and symp-
tomatic, the latter being the one that con-
cerns us here. Symptomatic means that it 
occurs in association with some other dis-
ease, certain neoplasms enumerated below 
being one group of these diseases. 
Occurrence of Hemolytic anemia in some 
neoplastic diseases : 
1. in 15 % of cases of chronic lympho-
cytic leukemia, 
2. 7% of cases of Hodgkin's disease, 
3. commonly in lymphosarcoma and 
giant follicular lymphosarcoma, 
4. rarely in chronic myelocytic leukemia. 
Similar antibodies as detected by the 
antiglobulin (or Coombs) test are also 
found in virus pneumonia and collagen 
disease. 
Two mechanisms in the formation of 
these peculiar antibodies have been sug-
gested: 
1. Alteration in the patient's erythrocytes 
causes them to act as antigens, which 
in turn are responsible for a specific 
immune response by the patient. 
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2. The original stimulus is non-specific but 
causes an outpouring of globulin from 
the patient's immune-body forming tis-
sues and this globulin is what is detected 
by the Coombs Test. 
The means by which these erythrocytes 
are actually destroyed in t hese anemias is 
open to a g reat deal of question. It has 
been suggested that the antibodies coat the 
outer surface of the erythrocytes, thus 
making them more susceptible to mechan-
ical destruction by the normal trauma 
encountered in the circulation, for it has 
been demonstrated that erythrocytes so 
coated with antibody have an increased 
mechanical fragility. Other suggestions in-
clude the following: 
1. The presence of antibody at the cell 
membrane alters the metabolism at the 
membrane surface, leading to sphero-
cytosis and subsequent destruction in 
the spleen or circulation. This mechan-
ism is fel t by some authorities to be 
unlikely because of the speed with 
which hemolysis has occurred in some 
studies. 
2. Auto-agglutination and stagnation re-
sulting from the antibody coating causes 
cellular ischemia and a release from the 
erythrocytes of substances which hasten 
erythrocyte destruction. There is no dir-
ect evidence to support this contention . 
3. The coating by antibody makes the ery-
throcytes more liable to phagocytosis. 
The hemolytic anemias so far discussed 
have been in association with the lympho-
mas and leukemias but further studies by 
W yman have shown that hemolytic anem-
ias may be associated with carcinomas. In 
a study involving 26 patients, the results 
may be briefly summarized as follows : 
Moderately increased hemolysis ..... 4% 
Slightly increased hemolysis . . 54~ 
No significant change . 42% 
In these studies, fecal urobilinogen was 
used as the index of hemolytic severity. 
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Wyman also found that by utilizing the 
Ashby technique for differential agglutin-
ation, the erythrocyte life-span was short-
ened in excess of the expected, in 15 out 
of 16 patients selected from the above 26. 
A later study indicated that in the latter 
group there was an increased acceleration 
in this process as the severity of the disease 
progressed. The mechanism of hemolysis 
in these hemolytic anemias associated with 
carcinomas is unknown. 
Another interesting g roup of hemolytic 
anemias is seen in patients in whom no 
other hemolytic mechanism can be dem-
onstrated or auto-antibodies detected. The 
usual features of a hemolytic anemia are 
present as well as other findings such as 
leukopenia and thrombocytopenia. The 
bone marrow is active. This syndrome is 
common not only to some of the lymph-
omas but to many other diseases not dis-
cussed in this paper. The cardinal feature 
is splenomegaly. The mechanism here is 
very poorly understod but it has been sug-
gested that in the affected spleen there is 
an increased circulatory stasis causing the 
increased erythrocytic destruction. 
RELATIONSHIP TO BONE MARROW 
METASTASES 
Myelopthisic anemia is defined as an 
anemia associated with space occupying 
disorders of the bone marrow and charac-
terized by immature leucocytes and nuclea-
ted red blood cells in the peripheral blood. 
The anemia here may not be severe. 
The commonest cause is metastatic car-
cinoma from: 
1. Breast 
2. Prostrate 
3. Lung 
4. Adrenals 
5. Thyroid 
Other causes include multiple myeloma 
in 5% of cases of that disorder and Hodg-
kin's Disease. 
145 
-'-Mechanisms of Anemias-----------------
The anemia is variable in degree. Com-
monly, the anemia is normocytic or it may 
be macrocytic but the most significant" 
factor is the presence of nucleated red 
blood cells in the circulation in numbers 
quite out of proportion to the anemia. 
Normoblasts make up most of these nucle-
ated cells but more primi_tive forms may be 
found . Reticulocytes are also increased. 
It has been assumed by many writers 
that mechanical limitation of hemopoietic 
tissue is the operative mechanism in myelo-
phthisic anemias associated with carcino-
matous metastases. The total quantity of 
red bone marrow is, however, often quite 
in excess of the normal amount. Further, 
it has been thought by others that hema-
topoiesis is actually stimulated, and sug-
gestions have been made that there may be 
a local nutritional deficieny because of the 
demands of the locally g rowing malignant 
cells. 
Interesting work on the relationship of 
myelopthisic anemia to bony metastases has 
been carried out by Shen and Hamburger. 
In a study of approximately 200 cancer 
patients, 40 % were found to have a hemo; 
globin within normal limits, the other 
60% showing evidence of definite anemia. 
Of the 40 with a normal hemoglobin, 
34 had evidence of bony metastases as 
shown by sternal or iliac aspiration. The 
60 with an obvious anemia, however, 
showed only a 20 incidence of bony 
metastases. These findings would natu rally 
lead to two conclusions : 
1. the finding of an ·anemia is not evi-
dence of bone marrow involvement, 
2. the incidence. of anemia is no greater 
in the presence of metastases. 
These same two workers also drew an 
interestjng comparison between the anemia 
co-existing with a chronic infection and 
that associated with bony metastases. Both 
anemias have many characteristics which 
are alike morpholog ically. For example: 
1. the anemias are usually slight or mod-
erate (hemoglobin over 60 ) . 
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2. they are normochromic or slightly 
hypochromic, 
3. reticulocyte counts are normal or 
slightly increased, 
4. n~rmal plasma bilirubin, 
5. neither is amenable to treatment with 
iron or liver. 
In addition, using cobaltous chloride, 
Shen and Hamburger were able to demon-
strate some increase in erythropoietic activity 
in both ane~ias, suggesting that, consider-
ing their morphologic similarity, their 
etiologies are related . This concept is 
plausible in view of the fact that many, if 
not all , malignancies have some zonal 
inflammation and necrosis associated with 
them. 
EFFECfS OF THERAPY 
Ionizing Radiation 
Exposure to ionizing rad iation in the 
course of treatment for neoplastic disease 
can lead to the production of an anemia 
not infrequently superimposed on a p,re-
existing anemia. The effects arise from the 
action of the electro-magnetic energy 
waves. The results depend on two factors : 
1. the kind of radiation 
2. the susceptibility of the affected cells. 
Hemopoietic tissue is par.ticularly ~us­
ceptible to ionizing radiation, particularly 
x-rays and gamma-rays which both pene-
trate the tissue readily. 
However, routine radiation therapy un-
commonly leads to a permanent or danger-
ous modification of the blood picture. 
Circulating erythrocytes are unaffected ex-
cept by severe irradiation. In Hodgkin's · 
disease and leukemia, it has been found 
that in some cases the number of erythro-
cytes has actually increased following ir-
radiation, especially if th~ underlying 
disease has been favorably treated . 
However, if prolonged therapy and 
large doses are administered, sometimes 
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patients with a lymphoma will show evi-
dence of a marked and persistent depres-
sion of erythropoiesis. 
Absorption of ionizing radiation by the 
cellular molecules leads to a series of chem-
ical changes dependent on the initi~J 
ionizing effect of incident electromagnet_lC 
waves of given wavelengths on certam 
chemical groupings. For example, sulf-
hydryl group containing enzymes have 
been found to be readily inactivated. There 
is an inhibition of both RNA and DNA 
synthesis which in turn leads to arrests in 
the erythropoietic tissues followed by a 
subsequent resumption characterized in 
some cells by the formation of bizzare 
mitotic figures. The synthesis of protein by 
the erythropoietic cells is, however, appar-
ently unaffected. Whatever the detailed 
chemistry behind the process, the end_ rt~­
sult is a suppression of erythrop01es~s 
leading to the picture of the aplash_c 
anemia. Other factors, of course, contn-
bute to this suppression, such as the well -
known effects of irradiation on blood 
vessels. It should be pointed out, finally, 
in relation to this mechanism, that the 
apiastic anemias following irradiation are 
usually not too serious and, therefore, as a 
rule, dQ not present clinical problems. 
Cbemotberapeu~ Drugs 
Generally speaking, most of the known 
cancer chemotherapeutic drugs depress the 
bone marrow in varying degrees depend-
ing on the drug and the amount admin-
istered. Most of the effects observable in 
the bone marrow are attributable to the 
fact -that bone marrow cells have a higher 
metabolic and mitotic rate than most other 
cells in the body and, thus, although the 
drug mechanisms of action are the same 
for all body cells, they tend to be more 
pronounced In a very active tissue such as 
bone marrow. Some of these drugs inter-
fere with folic acid metabolism, others are 
purine antagonists, still othets are alky-
lating agents, and, for others, the mechan-
ism of action is as yet not understood. 
Whatever their mechanism of action, how-
ever the over-all result is the same, namely 
a d;pression of the hemop~ietic tissues, 
which in turri causes an anemta. 
NUTRITIONAL FACfORS 
It is well known that in well advanced, 
serious metastatic disease the patient fre-
quently presents as generally malnourished 
and weakened . This effect is due both to 
the direct physical effects of the disease 
and psychic influences, the latter not un-
commonly suppressing the appetite. ~ancer 
cachexia as a single cause of anemJa has 
rarely, however, been proven. 
Of all the factors essential to normal 
erythropoiesis, Vitamin "B12 and ir~n ~r_e 
the only two which have any real stgmft-
cance etiologically in anemias associated 
with neoplastic disease. There are_ .two pos-
sibilities which have on occaswn been 
thought to be responsible for a Vitami_n 
B12 deficiency, and , therefore, an ~nemta 
resembling that of pernicious anemta: 
l . the absorption of Vitamin_ B12 is inter-
fered with because of the presence of a 
gastric carcinoma which upsets both the 
normal gastric secretion and the intrin-
sic factor, 
2. storage of Vitamin B12 is interfered with 
because of the p~esence iil the liV:er of 
massive hepatic metastases. Even when 
these metastases are present, it does not, 
however, follow that there will be a 
Vitamin B12 deficiency. 
Iron deficiency has been reported in 
cases of total ga.strectomy performed for 
treatment of gastric carcinoma. 
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ANEMIAS IN LEUKEMIA 
In acute leukemia, hemorrhage is often 
a factor but this fact does not account for 
the anemia which may be encountered be-
fore there is any evidence of bleeding. In 
the chronic forms of this disease, bleeding 
is rarely a factor to be considered and it is 
interesting to note that there is no evi-
dence to support the contention that there 
is a deficiency of essential substances 
which causes the anemia. Other suggested 
mechanisms include: 
1. crowding out (myelophthisis) , 
2. excessive red blood cell destruction, 
myelocytic anemia, the life span of the 
erythrocytes has been found to be short-
ened in varying degrees. Thus, it is pos-
sible that there is some intrinsic defect in 
these cells. 
In chronic lymphocytic leukemia, the 
life span is normal in most cases but frank 
autoimmune hemolysis is a finding not 
unusual in these cases. This last finding is 
rare in myelocytic and acute leukemic 
disease. 
Lastly, studies using radioactive Fe59 
have shown that in patients with leukemia 
erythropoiesis is normal or increased. 
3. a lowered red blood cell survival time. NEOPLASMS CHIEFLY INVOLVING 
THE LYMPH NODES 
These are considered in turn. 
Crowding out is supported by the fact 
that as irradiation therapy reduces the 
leucocytosis and so leads to a clinical re-
mission, the severity of the associated 
anemia also decreases. However, in many 
cases, the increased leukopoietic activity 
has been found to be co-incident with an 
equally increased activity on the part of 
erythropoietic tissue, and yet in spite of 
this there is still an evident anemia in the 
peripheral blood. 
There is some evidence to support the 
contention that there is an excessive des-
truction of erythrocytes in leukemia. This 
evidence includes the finding of hepatic 
hemosiderosis in some cases, while in 
others, an increase in the stools and urine 
of the products of erythrocyte destruction 
has been found. 
A third suggestion is that the survival 
time of erythrocytes is lowered. In chronic 
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1. Giant Follicular Lymphoma 
2. Lymphosarcoma 
2. Reticulum Cell Sarcoma 
4. Hodgkin's Disease 
An anemia is often absent in the first 
three mentioned, however, it is more com-
mon in Hodgkin's disease. This anemia 
tends to be normocytic. In Hodgkin's dis-
ease the anemia may be very severe, and in 
these cases, is likely to be myelophthisic in 
character with, however, li ttle associated 
lymphadenopathy or splenomegaly. Some-
times in Hodgkin's disease, and less com-
monly in the first three mentioned, an 
acute hemolytic anemia of the symptomatic 
1type may be seen, in which case it may be 
characterized by maq-ocytosis, spherocytosis, 
and even a d~le increase in erythrocyte 
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fragility. In these latter types of anemia, 
the spleen is also usually affected, showing 
splenomegaly. It is also likely that the 
anemias associated with these disorders are 
related to a shortened life span of the ery-
throcytes, somehow produced by the prim-
ary disorder. Therefore, therapy which is 
useful in treating the primary disease is 
also useful in d iminishing the severity of 
the anemia; iron , liver extracts and Vita-
min B12 therapy alone are of no therapeu-
tic value in diminishing the anemia. 
MULTIPLE MYELOMA 
Anemia as a symptom may be one of the 
reasons for a patient with multiple mye-
loma presenting himself to his physician . 
This anemia is one of the commonest fea-
tures of the disease and is rarely absent 
from at least part of the course of the 
disease. The picture of the anemia is 
usually characterized by the following 
features: 
1. Hemoglobin-6-10 gms./lOOml. 
2. R B C -2-4 million per cu. m.m. and 
usually normocytic, but if the dis-
ease is severe may be macrocytic. 
This anemia is thought to be <the result 
of a depressed erythropoiesis but is rarely 
associated with the autoimmune type of 
hemolytic anemia previously discussed. The 
reason for the depressed erythropoiesis is 
unknown at present. 
CONCLUSIONS 
Quantitatively, the anemias resulting 
from chronic loss of blood are the most 
NOVEMBER, 1961 
important. The mechanisms of these anem-
ias are also the best understood, at least in 
principle if not in detail. Our understand-
ing of mechanisms in hemoly6c anemia, 
and in those anemias associated with met-
astatic neoplastic bone disease is incom-
plete. It is perhaps significant that most 
of the previously discussed mechanisms are 
also operable in non-neoplastic disease, 
suggesting that the effects of neoplasms 
on erythropoiesis are not specific. 
Clinically, these anemias can be diagnos-
tically and prognostically quite important. 
Others are not very severe nor very im-
portant to the diagnosis . Some of these 
anemias, particularly those associated with 
chemotherapy and irradiation are import-
ant to understand because it is not uncom-
mon for such therapy to be discontinued 
because of severe hemopoietic depression 
which then becomes more serious than the 
neoplastic disease itself. 
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• Hypercalcemia 
Disease 
m Malignant 
CATHERINE M . COLE, '62 
INTRODucriON · 
In recent years, there has been considerable study of the hypercalcemia syn-
drome which occurs in a wide ·variety of diseases. Reports of hypercalcemia have 
been made in connection with the following entities: H ypercalcemia of infants ; 
Vitamin D intoxication; Milk-alkali syndrome; Hypercalcemia that occu rs occas-
ionally in patients with hyperthyroidism ; Hypercalcemia due to acute osteoporosis 
of disuse, especially in young people immobilized in plaster or with pol iomyelitis, 
also in older people with Pagefs disease; Boeck's sarcoid ; Hyperparathyroidism; 
Neoplasm, with or without demonstrable skeletal metastases ; as well as Iatrogenic, 
due to accidental parathormone overdosage or too vigorous pa.renteral replacement 
therapy in an attempt to treat hypocalcemia. In this review, the interesting finding 
of hypercalcemia in the presence of malignant disease will be studied. 
PHYSIOLOGY OF BLOOD CALCIUM 
The average serum calcium values vary 
from 9.5 to 10.5 mg. per 100 ml., thus 
readings of 11 .0 mg. or above are consid-
ered to indicate a state of hypercalcemia. 
The narrow limits of normal serum cal-
cium are a result of numerous processes, 
many as yet not understood, which contri-
bute to physiological calcium homeostasis. 
The following is a simplified resume of 
blood calcium control. Calcium enters the 
blood by three main routes; absorption 
from the small intestine, resorption from 
bone and by the parenteral route. Gastro-
intestinal absorption in turn depends on 
specific factors; the pH of the intestine, 
the nature and concentration of the anions 
present, and the presence of Vitamin D . 
Resorption from bone is in direct response 
to the stimulus of parathormone which 
activates the osteoclasts, promoting decal-
cification. 
Calcium is removed from the blood by 
excretion int o the large intestine, excre-
tion into the urine and deposition in the 
bones. The majority of fecal calcium is 
actually the unabsorbed calcium taken in 
the diet. The amount of calcium in the 
urine ,average 150-180 mg. per 24 hours) 
is affected directly by changes in renal 
efficiency as well as indirectly by the 
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action of parathormone. 
In the blood, 40 of the calcium is com-
bined with protein, chiefly albumin, thus, 
indirectly, the blood protein concentration 
determines the amount of calcium which 
can be held in a non-diffusible form. The 
remainder of the calcium consists of free 
ions and is diffusible, along with a small 
percentage which is combined with citrate. 
Hypercalcemia occurs whenever this bal-
ance is upset in favor of more calcium 
entering the blood stream than leaving it. 
SIGNS AND SYMPTOMS 
OF HYPERCALCEMIA .. 
The clinical aspects of hypercalcemia are 
well illustrated in the following case re-
port, recorder by P. F. Lucas in the British 
Medical Journal.• · 
A man, aged 49, had been perfectly well 
until six weeks before admission to the 
hospital. For three weeks, he was vaguely 
unwell but able to work; he then became 
increasingly drowsy, so that he would 
sleep all day and, in the last week, com-
plained of abdominal discomfort, constipa-
tion, polyuria, polydypsia, and vomiting 
so severe that he could not keep even 
fluids down in the previous 48 hours. He 
had lost 24 pounds in this time. 
The most striking clinical feature on 
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admission was drowsiness, so marked that 
he would drop off to sleep while talking . . 
General examination was normal. The only 
abnormal findings on special examination 
were a serum calcium of 16 mg./100 ml. 
and an inorganic phosphate of 2.2 mg./100 
mi. X-ray examination showed chest, skull, 
spine, pelvis and femurs to be normal . 
A diagnosis of hyperparathryoidism was 
made and the patient was put on a high 
fluid intake. During the next ten days, 
vomiting almost ceased and abdominal dis-
comfort subsided. His drowsiness gradually 
increased. The serum calcium rose steadily 
to 18 mg./100 ml., the phosphate remain-
ing below 3 mg./100 ml. The urine output 
fell and the blood urea nitrogen rose to 90 
mg./100 ml. Urina ry two calcium excretion 
was 350 and 550 mg. in 24 hour periods. 
On the eleventh day after admission, an 
exploration of his neck was undertaken at 
which a small swelling in the thyroid 
proved to be a cyst; no other abnormality 
was found . 
He remained unconscious for 36 hours 
after operation and his condition appeared 
terminal. The use of hydrocortisone caused 
a decrease in his serum calcium to 14 
gm./100 ml. on the sixth post-operative day. 
He improved .enough to be able to recog-
nize his relatives, talk, and take fluids . 
From the sixth to. ninth day, there was 
considerable difficulty in maintaining elec-
trolyte balance, and he became increasingly 
drowsy, the blood urea nitrogen rising to 
158 mg./100 ml. and the calcium to 16.2 
mg./100 ml. He died nine days after 
exploration in spite of continued cortisone 
therapy. Sodium E.D.T.A. had no effect on 
this terminal rise in calcium. 
Autopsy showed widespread abdominal 
carcinomatosis, with 'the primary, histologi-
cally an adeno: arcinoma, in the tail of t he 
pancreas. There was also pancreatitis and 
marked fat necrosis in the omentum. Mac-
roscopic examination of several bones fail-
ed to show any metastases. 
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Thus, in cases with a rapid onset, the 
gastrointestinal symptoms include anorex-
ia, nausea, vomiting and constipation 
which result in weight loss. The central 
nervous system symptoms include drow-
siness, lethargy, confusion and disorienta-
tion which proceed to coma. Muscle weak-
ness with hypotonia is often present. Renal 
manifestations consist of polydypsia, poly-
uria, nocturia and a dry mouth. If 'these 
are sustained for some time, deposits of 
calcium occur within the renal tubules and 
in the renal pelvis with eventual nephro-
calcinosis and stone formation , leading to 
mechanical impairment of kidney function 
and eventual renal failure. 
Myers found that the neurological fea-
tures were predominant in this syndrome, 5 
whereas Warwick et al found symptoms 
referable to the gastrointestinal tract 
appearing as 74% of the recorded 
symptoms.10 
TYPES OF MALIGNANCY 
ASSOCIATED WITH 
HYPERCALCEMIA 
With Skeletal Metastases 
Tumors which commonly involve bone 
or the bone marrow, such as mammary, 
bronchogenic or renal carcinomas, as well 
as multiple myeloma and the lymphoma-
tous diseases, have been the cause of hyper-
calcemia. Mammary carcinoma is the com-
monest malignancy associated with this 
syndrome. Although thyroid and prostate 
malignancies commonly metastasize to 
bone, hypercalcemia is rarely a complicat-
ing feature. The growth of the tumor in 
the osseous system causes its breakdown, 
with a liberation of calcium into the blood 
stream. This upsets the physiological bal-
ance and calcium is rapid ly excreted by the 
kidneys until the maximum calcium load 
is exceeded, then hypercalcemia becomes 
evident. Thus, hypercalciuria always pre-
cedes hypercalcemia in the presence of 
normal renal function . 
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Without Skeletal Metast3Ses 
Much less frequently hypercalcemia has 
been recorded in the presence of tumors in 
which no clinical or radiological evidence 
of osseous invasion was apparent, and 
when post-mortem examination has shown 
no secondaries in the bone.7 Such tumors 
include a wide variety of malignancies, the 
commonest one recorded being the hyper-
nephroma of the kidney. 7 Others include 
carcinoma of the G.I. tract, uterus, ovary, 
testicle, and malignant lymphoma. 
The cause is obscure but two mechan-
isms have been postulated to explain the 
development of hypercalcemia in such 
cases. 
1. Some metabolic activity of the tumor 
itself, which may cause bone resorption 
without actually invading the skeleton. 
2. The production by the tumor of a sub-
stance similar to parathormone whic:h is 
injected into the blood stream, leading 
to all the signs of hyperparathroidism. 
Neither of these theories is supported 
by direct evidence. 
DIAGNOSIS 
Since hypercalcemia can cause death fairly 
rapidly, its diagnosis is essentiaL Every 
physician should be suspicious if the above 
symptoms appear, especially in a proven 
case of malignancy, and serum calcium and 
blood urea nitrogen studies should be 
undertaken immediately. Serial laboratory 
tests are essential, especially in gauging the 
response of the patient to treatment. 
The most important condition to be con-
sidered in the differential diagnosis is 
hyperparathyroidism. The signs and symp-
toms may be identical but those associated 
with hyperparthyroidism a.re often more 
insidious in their onset. It has been report-
ed that in patients with neoplastic disease 
and hypercalcemia, the serum calcium is 
elevated and the serum phosphorous is 
expected to be either normal or slightly 
elevated, whereas in hyperparathyroidism 
the serum phosphorous level is reduced. 
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Recently, a few cases have been recorded 
where normal serum phosphorous levels 
were found in hyperparathyroid ism, 2 thus 
this is not always a differentiating point. 
Two additional tests, the tubular reabsorp-
tion of phosphorous, and the ten day 
course of corticosteroid therapy have been 
used to differentiate the causes of hyper-
calcemia. In some instances a parathyroid 
exploration is resorted to in an effort to 
confirm the diagnosis. 
Another condition to be excluded is 
central nervous system metastasis in known 
cases of malignancy. The symptoms of 
drowsiness, dizziness, dysarthria and con-
fusion may lead to a strong suspicion of 
brain metastasis, but there is an absence of 
localizing neurological signs in hypercal-
cemia. These central nervous system symp-
toms have also been mistaken for psy-
choses, as a diagnosis of Alzheimer's Dis-
ease was made on a patient with hyperne-
phroma and hypercalcemia. ' 
A careful history is often helpful in rul-
ing out the other causes of hypercalcemia 
listed in the introduction. 
MANAGEMENT 
A. Measures to reduce the serum calcium 
1. Adequate hydration to promote cal-
cium output. This may require the 
use of intravenous fluids if the pa-
tient is nauseated and vomiting. 
B. Treatment of the underlying disease 
(i.e. the neoplasm) 
1. Medical: 
a) Alteration of hormone environ-
ment by administration of estro-
gens, androgens or corticoster-
oids. 
b) Chemotherapy, including nitro-
gen mustard and vincaleuko-
blastine. 
2. Surgical : 
a) Removal of the tumor if prac-
tical. 
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b) Castration, adrenalectomy or 
hypophysectomy, especially as 
palliative measures in cases of 
mammary carcinoma. 
3. Radiotherapy: 
a) Radiation to the tumor. 
b) Radiation of localized osteolytic 
metastases. 
The use of sodium ethylenediamine 
tetra-acetate (sodium EDTA) , a chelating 
agent, which forms a soluble chelate with 
calcium and enchances its renal excretion 
has been disappointing. 
PROGNOSIS 
With treatment directed at lowering the 
serum calcium, the symptoms of hypercal-
cemia are reversible. Sustained relief of 
symptoms depends on the outcome of the 
treatment of the cause of the hypercal-
cemia. 
SUMMARY 
The causes of hypercalcemia are listed 
along with a short review of the blood 
calcium physiology. Hypercalcemia in ma-
lignant· disease is illustrated with a case 
report which points out the major symp-
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toms related to this syndrome. The types 
of malignancy associated with hypercal-
cemia, with and without bony metastases 
include mammary, bronchogenic and renal 
carcinomas, as well as multiple myeloma 
and the lymphomas, mammary carcinomas 
predominating. The differential diagnosis 
is difficult in the case of primary hyper-
parathroidism. A resume of the manage-
ment of hypercalcemia in malignancy in-
cludes immediate t reatment of the hyper-
calcemia by restoration of proper fluid 
balance and then appropriate treatment of 
the underlying malignancy. 
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Student Research 
The edi tors of th is journal feel that under-
g rad u:! te medical research is an invaluable part 
of today's scient ifically oriented physician, as 
well ~ s an enjoyable experience with many 
benefi ts. Many year after the frustrations of 
word for word note-taking and the sweat be-
fore t·xams h:I.Ve been forgotten, the memories 
of many hou rs spent around the blackboa rd , the 
appara tus o r even the coffee table, sharing the 
personal experience of a highly qualified teacher 
will be remembered. The invaluable training of 
research, involving hours of reading, exacting 
experimentation, and finally the compilation 
of :1 report and summary leaves the medical 
student in a better position to take advantage 
of the clinical materia l which presents itself in 
h i~ practice, and, th rough the medium of scien-
tific journals, records his obesrvations and con-
clusions, to the material benefit of him elf and 
his fellow physicians. 
Th is year, we inaugurate a section of the 
Journ~ l devoted to student research . 
THE OXYGEN PARADOX 
Prior to the Second World War, certain 
French and German aviators discovered a 
paradoxical effect of oxygen. Following a 
period of moderate hypoxia, precipitated by 
any one of several reasons, the inhalation of 
pure oxygen from their face masks often 
brought on psychomotor disturbances such 
as Joss of co-ordination , decreased powers 
of discrimination, perception, and judg-
ment, muscle cramps, and in severe cases, 
momentary Joss of consciousness. Sporadic 
reports in the research literature concern 
human experiments and studies of psycho-
motor responses almost exclusively. Only 
three investigations have been carried out 
on animals to date. 
In the series examined in the Depart-
ment of Pharmacology this summer, cats 
were chosen to study the effect of breath-
ing of pure oxygen following a period of 
increasing and severe hypoxia, upon the 
heart rate, respiratory rate, blood pressure, 
rectal temperature, and frontal and occi-
pital cerebral cortical activity. 
A decompression tank was employed to 
raise the anesthetized animal to simulated 
altitudes of 25,000 or 30,000 feet. Record-
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ings of the above parameters were obtain-
ed from elect rical or thermocouple devices; 
the Grass polygraph yielded tracings of all 
parameters except rectal temperature in 
which case a thermocouple was used. 
In a pilot series of experiments, it was 
found that if the blood pressure was allow-
ed to fall by 30 to 50 per cent in a state of 
increasing hypoxia, and the cat then was 
made to breathe pure oxygen, maximum 
effects were obtained. Later, comparisons 
were made with animals allowed to con-
tinue to the end point in severe hypoxia. 
Within twenty to forty seconds fo1Jowing 
the intake of pure oxygen, the blood pres-
sure fell precipitously, an extreme brady-
cardia arose, apnea set in, and electro-
encephalograms were depressed markedly. 
In the cats allowed to continue in a state 
of severe hypoxia, similar results were re-
corded, but only after a time interval three 
to four times as long as the "oxygen" 
animals. Rectal temperature changes were 
not significant. 
The mechanisms of action of the oxygen 
paradox are likely one or several of the 
following: 
1. further severe cerebral ischemia due 
to a relative passive cerebral blood 
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pressure collapse when renewed peri-
pheral circulation of oxygen causes 
peripheral vasodilation. 
2. oxygen poisoning of vital brain stem 
centers, especially the respiratory 
center. 
3. reflex cerebral vasoconstriction upon 
the administration of pure oxygen. 
4. build up in the brain of toxic met-
abolic products such as lactic acid, 
that cannot be removed when a pas-
sive decrease in cerebral blood pres-
sure arises. 
If oxygen is administered in concentra-
tions somewhat less than 100 per cent, the 
oxygen paradox will not arise. Also, a 
hyperphysiological concentration of C02, 
administered with a high 0 2 concentration 
exerts a protective effect. 
The clinical applications of these find-
ings are obvious as far as aviation medicine 
is concerned. It should also be pointed out 
that oxygen paradox can arise in patients 
suffering from severe and chronic obstruc-
tive pulmonary disease, if one treats a 
hypoxic crisis by the administration of 
pure oxygen. 
This work was supervised and suggested 
by Dr. C. W . Gowdey, professor of Pharm-
acology. 
Loren Amacher, '62 
Department of Pharmacology 
Summer of 1961 
INCORPORATION OF CYTIDINE 
DIPHOSPHATE CHOLINE AND 
SERINE IN PERIPHERAL NERVE 
DURING WALLERIAN 
DEGENERATION 
It is well known that if a peripheral 
nerve is cut, the portion of the nerve distal 
to the point of section undergoes a series 
of changes known as W allerian degene.ra-
NOVEMBER., 1961 
tion. This is associated with a proliferation 
of Schwann cells which are responsible for 
the formation of the myelin sheath. The 
following investigation was proposed to 
study the labelling of the myelin phos-
phatides (i.e., the plasmalogens and sphin-
gomyelin) , in comparison with the label-
ling in the phosphatides associated chiefly 
with grey matter (i.e., lecithin and phos-
phatidyl serine) , using C14 labelled cyti-
dine diphosphate choline and serine as 
precursors. 
The right sciatic nerve of rats was sec-
tioned at the level of the greater trochanter 
of the femur and allowed to degenerate. 
After 4, 8, 16, or 32 days, the animals 
were sacrificed and the sciatic nerves were 
removed, the left nerve being used as a 
control. The nerves were homogenized and 
incubated in a buffered medium with 
known amounts of cytidine diphosphate 
choline-C'• and serine-C14 . The lipids were 
extracted, purified and divided into an 
alkali-stable fraction (the myelin lipids) 
and an alkali-labile fraction (mainly grey 
matter lipids) . 
In control nerves and during the first 
32 days of Wallerian degeneration, no sig-
nificant amounts of cytidine diphosphate 
choline or serine were incorporated into 
the alkali-stable plasmalogen-sphingomy-
elin fraction. However, both compounds 
were incorporated readily into the alkali-
labile glycerophosphatide fraction . Leci-
thin and phosphatidyl serine in the latter 
fraction showed a steady increase in label-
ling as the nerves degenerated. Phospha-
tidyl serine was labelled more rapidly 
reaching a peak at 16 days degeneration. 
The results will be interpreted in the 
light of previous studies and studies now 
in progress in the Department of Bio-
chemistry. 
Keith Fidler, '62 
Department of Biochemistry 
Summer of 1961. 
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Historical 
Dr. Walter Bapty, Meds '06, reminisces 
on some of the early teachers and p ro-
cedures around the Medical School. 
NOTES ON SOME TEACHERS 
AT THE MEDICAL SCHOOL 
My first introduction to medicine com-
menced with a lecture in Anatomy, deliv-
ered by Dr. Hadley Williams, a man with 
a brilliant mind, dedicated to his work. 
Physically, he was not a large man, but he 
did command respect with his piercing 
eyes, a black moustache, and a clear pene-
trating voice. Because he was a rapid and 
fluent speaker, he kept order in class, 
which was made up of "unruly" students 
of 1905-06, as both years received the 
same lecture. 
Hadley was a great anatomist, and he 
knew his subject thoroughly, having re-
ceived his F.R.C.S. in England. It was said 
that shortly after his arrival there, and 
without any coaching, he had taken his 
primary and passed in anatomy. When lec-
turing, he showed artistic talent, for he 
illustrated his subject on the blackboard 
by using colored chalk. He bad the un-
usual ability of drawing with both hands, 
when picturing symmetrical parts, such as 
cross sections of the brain, cord or chest. 
Much of our anatomy was taught in the 
classroom, with the help of Gray's text-
book. Afternoons were spent in dissection 
and our teacher was our demonstrator. The 
details of Dr. Williams's lectures have been 
forgotten, but he did impress upon us the 
importance of Embryology, and its bearing 
on many hereditary malformations. Our 
class had only one term of Anatomy with 
Dr. Williams, for the following year, he 
became an Associate Professor of Surgery. 
Dr. Ed Seaborn -followed ~as Chief in the 
Anatomy Departinent. Very different in 
appearance, lacking the fire and brilliance 
of his predecessor, Dr. Seaborn created 
rather a feeling of assurance and faith in 
our chosen profession. It must be remem-
bered that for the most part, our teachers 
were general practitioners. However, the 
period of specialization was beginning. Dr. 
Hugh McCallum was devoting himself to 
Internal Medicine. He persuaded Dr. John 
MacGregor of Nebraska, to assist him and 
to teach pathology at Western. Doctors 
John Wishart and Hadley Williams were 
surgeons; Doctors Meek and Eccles con-
fined themselves to Obstetrics. I have only 
a dim memory of Dr. Williams as a clini-
cal teacher. Some years later, when visiting 
Victoria Hospital, I observed him perform-
ing an operation, without a mask. Its 
absence was not unusual among older sur-
geons, and even at that date, a few senior 
men did not wear rubber g loves when 
operating. 
Names of many professors have eluded 
me, but I do recall Doctors Jim Campbell, 
and Nev for Physiology. It was not until 
my third year that I was aware of the 
dynamic personality of Dr. Hugh McCal-
lum. Imposing in appearance, as he was 
over six feet in height, thick-set, and over-
weight, he was full of life and good 
natured humor. Due to his enthusiasm and 
inspiration, Medicine was a favorite sub-
ject. His instruction was chiefly clinical, 
and "Osler" was his t ext. He often quoted 
Osler's sayiug that pneumonia was "the 
captain of the men of Death" . Though he 
was in the prime of life another remark 
I remember was, "If pneumonia strikes me, 
it will be the end." That was prophetic far 
he succumbed to it not long after. 
· Dr. Walter Moorhouse, a professor of 
Medidne,·· .was -also· oo . the .staff: H e ·was 
pas:t his pr~e :.and . had lost all :~t;. _·Too 
dignified· a- bearing; coupled -with ·ascetic 
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face, did not appeal to the students, so his 
classes usually ended in an uproar. A quiet 
voice and a ready wit endeared Dr. Wis-
hart to all. Dr. John MacGregor was just 
commencing his duties as pathologist at 
Victoria Hospital, and instructor at the 
school. He was such a keen student him-
self, that he inspired all who came in 
contact with him. 
Shortly after, we graduated-and we did 
graduate! Our class of 1906 was so lacking 
in discipline that we were given a private, 
hush-hush convocation in the old Univer-
sity Building by Huron College where we, 
in all sincerity, took the Hippocratic Oath. 
The Flexner Report on Medical Educa-
tion was publ ished within a short time. 
Many of the findings were true, especially 
News And Views 
Western University was honored to have 
Dr. Otto Saphir present the sixteenth 
annual John A. MacGregor Memorial Lec-
ture on September 27, 1961. Dr. Saphir, 
distinguished pathologist from Michael 
Reese Hospital in Chicago, spoke on 
"Pyelonephritis Leota and its Role in the 
Etiology of Mal ignant Hypertension." 
The lecturer stressed that Pyelonephritis 
Leota is an asymptomatic, insidious cause 
of malignant hypertension, and showed 
how it caused proliferation of the renal 
NOVEMBER, 1961 
the lack of laboratories and other facilities. 
What that report could not discover was 
the consecration of a body of medical men 
who devoted their time and money towards 
the training of students in the concepts of 
good and honest medical practice. Such 
was my loyalty to Western University that 
when I discovered a copy of the Flexner 
report in the office of a high government 
official, I confiscated it and later destroyed 
it. Though this report did not give credit 
where credit was due, it had its part in 
leading to a higher and better standard 
of medical training throughout Canada 
and the United States. 
Walter Bapty, M.D. '06. 
April 27, 1961, Oshawa. 
arteriolar intima without producing an 
inflammatory reaction in the surrounding 
interstitial tissue. He went on to explain 
that the subcapsular petichial hemorrhages, 
seen in this syndrome, were due to the 
uremia inherent to the terminal stages. 
Dr. Fisher, head of the U.W.O. depart-
ment of Pathology, presided over the lec-
ture and closed the meeting by drawing 
attention to the keeness of the observations 
of Dr. Saphir which led to this hypothesis. 
George De Young, '63 
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Book Review 
Management of Hypertensive Diseases 
by Joseph C. Edwards, 439 pages, ECG 
and x-ray plates, C. V. Mosby Co., St. 
Louis. 15.00. 
This review is written in late 1961 and 
at least some of the criticism is based upon 
rapid developments in this field of medical 
therapeutics since the date of publication. 
Leonardo Da Vinci comments that "those 
who abridge works do injury to know-
ledge . . . " 
The painfully slow progress of thera-
peutics is based upon the careful observa-
tion of disease throughout its natural 
history and notation and reflection upon 
modifications which can be induced in its 
course. As such, a large portion of this 
book, relating to therapeutic experience 
under varying circumstances and complica-
tions, is interesting and instructive reading. 
Impressive is the meticulous care in dosage 
adjustment and its flexibility and the im-
portance of paient's intelligent coopera-
tion. The author is a polypharmacist, fre-
quently using three drugs simultaneously 
to achieve a "smoothing out" of irregular 
blood pressure response. 
Progress in the field now suggests com-
bination of thiazide with blocking or sym-
pathicolytic agent. The discussion of 
guanethidine seems to disregard the sig-
nificance of its long-delayed hypotensive 
effect, rendering the implied relation of 
the momentary blood pressure as a guide 
to the next dose of the drug, dangerous 
and misleading. 
Less common causes of hypertension are 
dealt with in a clear and helpful way. 
Technical detail of some of the more com-
plex diagnostic procedures are closely 
outlined. 
Discussion of cardiac dynamics and 
but so condensed as to be of little value 
to the reader. The section dealing with the 
controversy surrounding the " renal" basis 
for essential hypertension, adds nothing to 
the clarity of the controversy itself, nor 
does it seem relevant to the avowed pur-
pose of this volume. 
Allowing this criticism, this book repre-
sents a milestone in the clinical reporting 
of hypertension. Here is gathered, not in 
vague generality, but in specific detail, the 
author's method of treatment of individual 
patients. Various stages and complications 
are represented. The results of this treat-
ment are clearly portrayed with helpful 
diagramatic clarification. Relief of symp-
toms, altering physical and laboratory signs 
are shown for individual patients. How 
much more meaningful this approach may 
seem to the physician than is the stifling 
quotation of statistics applying to "signi-
ficant numbers", while individual tragedy 
or comforting success is buried in the 
"mean". 
That the careful, conscientious medical 
therapist has contributed to the comfort 
and longevity of the more severe hyper-
tensive, is clearly portrayed. That further 
advance-of significant comfort to the 
patient, has occurred since publication of 
this work, is cause for further optimism. 
The paper is shiny, the glare annoying. 
The printing is clear and the reproductions 
faultless. 
This book cannot now be recommended 
by this reviewer as an authorative source 
book on the current therapeutics in hyper-
tension, but it can be read with profit by 
those wishing the case report method of 
presentation, cataloguing the modification 
of hypertension by effective treatment. 
theories of pathogenesis are broad in scope, Sept. 22, 1961 ]. A. Lewis, M.D. 
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Abstracts 
USE OF TOTAL-BODY RADIATION 
IN THE TREATMENT OF FAR 
ADVANCED MALIGNANOES 
King, E. R., JAMA, 177: 610-613, 1961. 
For several decades, attempts have been 
made to use total-body radiation as a form 
of cancer therapy. Originally, there were 
attempts made with low-energy x-rays, 
radium, and, later, with the internally ad-
ministered radio-nuclides P32, Na2 \ K42, 
Au198, etc. Within the past 15 years, the 
production of the long half-life radionu-
clides, Co60 and Cs131, each with energetic 
gamma-ray emissions, has made available 
adequate and economical radiation sources 
for the delivery of nearly uniform doses to 
the human. In addition, interest has been 
generated regarding the uses of total-body 
radiation in the problem of the immun-
ologic response and the homotransplanta-
tion of organs. 
With this introduction, the author des-
cribed a two year study with cobalt-60 
irradiation. Exposure methods and dosi-
metry were discussed in some detail. Then, 
patients treated with a single dose of 
total-body radiation were compared with 
patients who were treated with multiple 
doses . 
In all, 17 patients with far advanced 
cancer were treated with total-body radia-
tion. Good palliative responses were 
achieved in 6 patients treated with small 
repeated doses. The results of 11 patients 
treated with a single dose varied. All patients 
were followed from the standpoint of 
gastrointestinal symptoms, cardiovascular 
symptoms, bacterial infections, and hema-
tology studies. Additional studies were 
done on the urinary excretions of amino-
acids. The clinical findings reportedly 
associated with acute radiation exposure 
were not significant in these latter 11 
patients. 
Robert Moffat, '62 
MALIGNANT MELANOMA 
James, A. G., JAMA, 176: 5-7, 1961. 
This author analysed 130 cases of malig-
nant melanoma over a 10 year period. His 
patients ranged from 13-91 years in age, 
and no cases were observed before puberty. 
A definite history of pre-existing mole at 
the site of melanoma was obtained in 63 
patients. 
Treatment consisted of a type of surgical 
excision: 
a) if the primary lesion was in close 
proximity to a regional node-bearing area, 
this area was radically resected whether or 
not there was demonstrable metastatic 
disease. 
b) if the primary lesion was distantly 
removed from the nearest nodal area and 
this area contained no clinical evidence of 
disease, then only wide excision was done. 
c) if the primary lesion was in an ex~ 
tremity with nodes involved, an amputa-
tion was done. 
No form of radiation was considered. 
Absolute survival rates were: 
42% for 3 years, 
32% for 5 years, 
19% for 10 years. 
The author felt that these end-result 
figures were not consistent with the teach-
ing that melanoma is the most lethal 
malignancy in man. 
Robert Moffat, '62 
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CHANGES IN BRONCHIAL 
EPITHELIUM IN RELATION TO 
CIGARETTE SMOKING AND 
IN RELATION TO LUNG CANCER 
A. P. Stout, New Eng. J . of Med ., 265:6, 
p. 253, 1961. 
In an attempt to correlate cigarette 
smoking and lung cancer, the authors dis-
sected the tracheo-bronchial tree from the 
lungs of 402 male, white patients dying 
with and without lung cancer. Each speci-
men was then divided into 208 sections, 
and, from among these sections, 55 sites 
were selected for microscopic study in each 
case. These were coded to eliminate bias, 
and each studied for the presence of three 
pathological findings : loss of cilia from the 
epithelial cells, increase in the number of 
rows of cells, atypism of cells. The obser-
vations were then recorded and statistically 
analysed in relation to smoking habits. 
It was found that each of the three vari-
ables increased rapidly with the amount of 
cigarette smoking, both in the number of sec-
tions showing the change, and in the degree 
of change. These changes were of somewhat 
the same magnitude in persons smoking 
heavily as in those who had died of lung 
cancer. In sections from non-smokers such 
lesions that were found showed, more 
often than not, only one of the above listed 
changes. In sections from heavy smokers 
and those who had died of carcinoma of 
the lung, atypical cells were found in every 
lesion that showed hyperplasia and loss of 
cilia. This does not, however, mean that in 
all cases the lesion would have become 
invasive if the patient had not died of 
some other disease. 
Robert F. Southern, '62 
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CARCINOMA OF THE BREAST 
R. J . Utzschneider, J. C. McCann Jr., New 
Eng. J. of Med., 263:871 , 1960. 
The report evaluates 245 new cases of 
carcinoma of the breast in a New England 
Hospital. Patients ranged in ages from 27 
years to 91 years, the average being 57.6 
years. 18.3% were between 70 and 79 years 
of age. The average length of time between 
the appearance of first symptoms or signs 
and hospitalization was 31 weeks, ranging 
from 1 day to 7 years. 16.3% revealed a 
history of cancer in blood relations. 
55% of all tumors were found on the 
left and 45 % were found on the right, the 
majority being found in the upper, outer 
quadrant. 72% were t reated with radical 
mastectomy, 11 % with simple mastectomy 
and 17% were considered inoperable. Of 
the 72% undergoing radical mastectomy, 
38% had histologic proof of involvement of 
the axillary lymph nodes, 62% having no 
involvement in this area. 
In the follow-up of 100% of the orig-
inal 245 cases, ·the five-year survival of all 
cases treated with radical mastectomy (i.e. 
176 cases) , regardless of node metastases, 
was found to be 69 0 , and ten year surviv-
al was 45 %. Of those who had no axillary 
metastases, 75 .2% survived for five years, 
and of those with axi llary metastases, 
47.8%. Of the inoperable cases, only 7% 
survived five years and of those with 
simple mastectomy, 25 % . 
Robert F. Southern, '62 
ACCESSORY ADRENOCORTICAL 
FUNCTION AFTER ADRENALEC-
TOMY IN PATIENTS WITH BREAST 
CANCER 
Sim. A. W ., Hobkirk, R., Blai r, D. W ., 
Stewart, H., Lancet, 2: 73-76, 1961. 
It is a well-known fact that bilateral 
adrenalectomy and oophorectomy may in-
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duce remarkable improvement m the 
course of metastatic breast cancer in 
women. However, sooner or later, renewed 
growth and multiplication of tumor cells 
lead to relapse and death. 
Why? Did the endocrine surgery deprive 
the malignancy of some essential factor for 
active growth, and the eventual relapse 
come about from the development of an 
accessory source of adreno-ovarian hor-
mones? 
With this question in mind, the investi-
gators studied 6 patients whose metastatic 
breast cancer had regressed after surgery, 
in order to try to detect any residual 
adreno-cortical function. Generally, the 
tests comprised serial estimations of adren-
al hormones and their metabolites in the 
urine and peripheral blood before, during, 
and after a post-operative period when 
cortisone therapy was stopped. 
Their findings, in patients whose cancer 
had relapsed, were identical with those 
in patients whose tumor had regressed, and 
they indicated that relapse of cancer is not 
associated with the development of func-
tioning adreno-cortical tissue. Also, no 
adrenal rests were demonstrated at 2 post-
mortems. 
Robert Moffat, '62 
CARCINOMA AND CUSHING'S 
SYNDROME 
Billinghurst, J. R., Thould, A. K., Galpin, 
0 . P., Hinton, J. M., BMJ, 490-493, 1961. 
In this article, the authors present 2 
cases in which carcinoma of the bronchus 
was associated with Cushing's Syndrome. 
There are presently 43 cases of non-adrenal 
malignancy in the literature associated 
with Cushing's Syndrome. A point of in-
terest is that there was no significant 
alkalosis in these 2 cases as in most of the 
others, but there was a definite hypoka-
lemia. 
As in previous cases, obesity, gain in 
weight, hypertension, thirst, polyuria, and 
hirsutism were all noted as clinical find-
ings. Interestingly enough, the develop-
ment of the syndrome was very rapid in 
all reported cases. Also, there was a high 
female incidence (19 of 43) . The authors 
discussed several theories as to why the 
syndrome might be associated with a ma-
lignancy but none were entirely satisfac-
tory. 
Finally, they stressed the need to be 
aware of such an association, partly to 
avoid the erroneous diagnosis that the 
primary neoplasm lies in the adrenal 
cortex, and partly to prevent the patient's 
undergoing a fruitless adrenalectomy when 
a primary neoplasm elsewhere is unsuspected. 
Robert Moffat, '62 
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ARREST OF PREMA1URE LABOR 
Bishop, E. H. and Wootersz, T.B., J.A. 
M.A. 178: 212, 1961. 
Premature labor occurs in about 10% 
of all pregnancies and is the most frequent 
complication during the last half of preg-
nancy. It is also well known that prema-
ture labor poses a great threat to the 
welfare of the fetus. 
In this study, the authors attempted to 
demonstrate the effect of a myometrial 
relaxant, inoxsuprine hydrochloride on the 
human uterus in premature labor. The 
study consisted of 156 patients in pre-
mature labor. Before treatment, several 
criteria had to be fulfilled : 
1. Pregnancy between 20 and 36 weeks. 
2. Evidence of premature labor such as 
dilatation of the cervix, bloody show, 
or abnormal uterine contractions. 
3. Cervix less than 4 em. dilated. 
4. Intact membranes. 
5. Absence of any complications contra-
indicating the continuation of preg-
nancy. 
When the drug was administered, it 
was found to have no effect on labor in 
25 % of all cases. In 11.5% of cases labor 
was interrupted for only a short period of 
time. In a third group labor was delayed 
for one week or longer in 21.2 % of pa-
tients but the fetus at delivery weighed 
less than 2500 grams. Finally in 42.3% of 
patients, labor ceased after inoxsuprine ad-
ministration and did not recur until the 
infant reached a birth weight of at least 
2500 grams. Results were even better in 
a more sdected group. 
In 66% of patients, it was found that 
premature uterine contractions ceased for 
a significant period of time with inox-
suprine therapy. 
Robert Moffat, '62 
JANUARY, 1962 
TRACHEOTOMY-
ITS COMPLICATIONS 
AND THEIR MANAGEMENI' 
Meade, J. W ., New Eng. J. Med. 265:519, 
1961. 
It has often been said that tracheotomy, 
one of the oldest operations in surgery, is 
one of the most frequently done improp-
erly, and most often mismanaged in the 
after-care. 
The author once again brings this to 
our attention by presenting a series of 212 
tracheotomies and their complications. 
The complication rate was 33% and the 
mortality 2.8% . 
The complications were discussed under 
operative and post-operative headings. 
Operative complications consisted of em-
physema (subcutaneous and mediastinal), 
pneumothorax and low incisions. Post-
operative complications were much more 
numerous. Pneumonia was noted in 11 
cases and resulted in 2 deaths. In 6 pa-
tients atdectasis secondary to obstruction 
from mucous plugs developed. Other post-
operative complications were endotrach-
eitis cannula difficulties, hemorrhage, 
sepsis, and carbon dioxide retention. 
It was also mentioned that meticulous 
post-operative care was most essential.. ~f 
the tracheal air was not kept well humtdt-
fied and the inner cannula frequently 
cleaned, then obstruction by mucous plugs 
and viscid secretions was bound to occur. 
It was felt that most complications were 
preventable and could be avoided by care-
ful operative technic and good post-
operative management. 
Robert Moffat, '62 
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